20
Unimark Remedies Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Lamotrigine, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 2009-278 - Rev 00
This Chemical Type CEP, issued on February 26, 2016, remains in force until September 22, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 1756 associated with this CEP further emphasizes